Abstract:Objective To explore the expression and clinical significance of high mobility group box 1(HMGB1) in stage ⅢB colon cancer.Methods Samples obtained from 72 patients with stage ⅢB colon cancer,who underwent surgery in Cancer Center of Sun Yat-sen University from Jun.1999 to May 2002,were analyzed with single-and double-staining immunohistochemistry for the expression of HMGB1 and infiltration of inflammatory cells.Another fresh tissue samples obtained from 10 patients with stage Ⅲ colon cancer,who underwent surgery from Aug.to Oct.2009,were analyzed with flow cytometry for the expression of CD3、CD45RO on the T cells,and the expressivities were then calculated.The expressive level and location of HMGB1,and the relationship of the expression to the infiltration of inflammatory cells and to 5-year survival rate of patients were analyzed.The independent risk factors influencing the prognosis were screened out by Cox risk regression model with the 5-year survival rate of 72 patients with stage ⅢB colon cancer as the dependent variable,and the clinical features,the expression level and location of HMGB1,and the infiltration density of CD3+ and CD45RO+ T cells as the independent variable.Results The expressions of CD3+ and CD45RO+ T cells in different degree were found in the cytomembrane of interstitial tissues of stage Ⅲ colon cancer.It was revealed by flow cytometry that 72% of the CD45RO+ T cells were also positive for CD3,and by immunohistochemical staining that the expression rate of HMGB1 was 90.3%(65/72) in the tissues of stage Ⅲ colon cancer,of which 81.5%(53/65) expressed on the nucleus alone and 18.5%(12/65) on both nucleus and membrane,the infiltration density of CD45RO+ cells was higher in the former than in the latter.The infiltration density of CD45RO+ T cells was the independent risk factor for the survival of patients with stage Ⅲ colon cancer.Although no correlation was noted between HMGB1 expression,both in quantity and in location,and prognosis,the survival rate of patients with HMGB1 expressed on nucleus alone was higher than that of patients with HMGB1 expressed on both nucleus and membrane after a 24-month follow-up(P<0.001).Conclusion The decrease of lymphocyte infiltration in the patients with HMGB1 expressed on both nucleus and membrane is companied with the decline of long-term survival rate of the patients with stage ⅢB colon cancer,implying the expressive style of HMGB1 may serve as one of the markers indicating the prognosis of patients with advanced local colon cancer.

Effects of High-Mobility Group Box-1 on Mucosal Immunity and Epithelial Differentiation in Colitic Carcinoma

Intestinal Epithelia and Myeloid Immune Cells Shape Colitis Severity and Colorectal Carcinogenesis via High-mobility Group Box Protein 1

25-hydroxycholesterol Regulates Migration, Invasion and EMT of Colorectal Cancer through miR-92a-3p/ACAA1/NF-κB Pathway

The Role of High Mobility Group Box B-1 in the Prognosis of Colorectal Cancer Based on the Changes in the Intestinal Mucosal Barrier

Role of high mobility group box chromosomal protein 1 in pathogenesis of ulcerative colitis in mice

HMGB1 Modulates Macrophage Metabolism and Polarization in Ulcerative Colitis by Inhibiting Cpt1a Expression

Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis

Dynamic changes and functions of macrophages and M1/M2 subpopulations during ulcerative colitis-associated carcinogenesis in an AOM/DSS mouse model

The Effect of HMGB1 on the Clinicopathological and Prognostic Features of Cervical Cancer.

Evaluation of colorectal cancer in ulcerative colitis reveals key immune factors during its malignant transformation

The role of HMGB1 in digestive cancer

Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice.

Increased HMGB1 Expression Correlates with Higher Expression of C-Iap2 and Perk in Colorectal Cancer

Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice

Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer

Correlation of CCL20 expression in rectal mucosa with the development of ulcerative colitis-associated neoplasia

Adeno-associated virus-mediated colonic secretory expression of HMGB1 A box attenuates experimental colitis in mice.

Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer

Expression and clinical significance of high mobility group box 1 in stage ⅢB colon cancer

Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model

Significance of CD10 for Mucosal Immunomodulation by β-Casomorphin-7 in Exacerbation of Ulcerative Colitis